Vision Point Advisory Group, LLC Annexon, Inc. Call Options Transaction History
Vision Point Advisory Group, LLC
- $473 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANNX
# of Institutions
140Shares Held
96.5MCall Options Held
0Put Options Held
63.4K-
Satter Management Co., L.P.7.41MShares$23.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$22.1 Million0.66% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$19.8 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$16.9 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $150M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...